WUXIA RIDGS

Serial Number 98874315
680

Registration Progress

Application Filed
Nov 26, 2024
Under Examination
Approved for Publication
Published for Opposition
Registered

Trademark Image

WUXIA RIDGS

Basic Information

Serial Number
98874315
Filing Date
November 26, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
680
Status Date
Jul 3, 2025
Application
Pending
Classes
040 042

Rights Holder

WUXI BIOLOGICS IRELAND LIMITED

99
Address
MULLAGHARLIN
DUNDALK, COUNTY LOUTH A91X56F
IE

Ownership History

WUXI BIOLOGICS IRELAND LIMITED

Original Applicant
99
DUNDALK, COUNTY LOUTH IE

Legal Representation

Attorney
Eric Lamb

USPTO Deadlines

All Deadlines Cleared

All 3 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

10 events
Date Code Type Description Documents
Jul 3, 2025 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jun 30, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jun 30, 2025 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jun 30, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
May 23, 2025 CNRT R NON-FINAL ACTION WRITTEN Loading...
May 23, 2025 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
May 23, 2025 GNRT F NON-FINAL ACTION E-MAILED Loading...
May 19, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 26, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Nov 26, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 040
(Based on Intent to Use) Custom assembling of materials for others; processing or treating of chemical reagents; processing of antibody drugs; custom manufacturing of Antibody drugs; custom production of biological preparations; processing of biomedical preparations; processing of biotechnology drug; processing of pharmaceutical preparations; custom manufacturing of pharmaceuticals; custom manufacture of biopharmaceuticals;
Class 042
(Based on Use in Commerce) Consulting services in the field of technology development; research and development of new products for others; research and development of new products; scientific research and development; pharmaceutical drug development services; pharmaceutical research services; biochemical research and development; development of pharmaceutical preparations and medicines; research and development services in the field of antibodies; biomedical research services;
First Use Anywhere: Oct 29, 2024
First Use in Commerce: Oct 29, 2024

Classification

International Classes
040 042

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"RID GS"